How long should we allow metformin to remain the bogeyman in CKD? Should MALA scare us from ever letting our patients benefit from metformin? Join us as we discuss some rare prospective data on metformin in moderate to severe CKD.
Background, summary
This week, we will discuss the AHA/ACC 2025 hypertension guideline update. Wow, have eight years flown by?
Background
This week, we will discuss the ACHIEVE trial. Will spironolactone achieve CV benefits in ESRD?
Background
The summer book club started in 2015, with one of the best books we have done in book club, Atul Gawande's Being Mortal. I think it should be required reading for all physicians. So now, in 2025, it is the NephJC Summer Book’s tenth anniversary (which represents our eleventh book). The history has been rich:
Background
This week, we will discuss the phosphate targets in dialysis. Are you aiming for HIgh or Low?
